期刊文献+

病程对1型糖尿病血脂、血尿酸水平及并发MS的影响 被引量:2

INFLUENCE OF THE COURSE OF TYPE 1 DIABETES ON PATIENT'S LIPID,URIC ACID AND METABOLIC SYNDROME
下载PDF
导出
摘要 目的探讨病程对1型糖尿病病人血脂、血尿酸水平及并发代谢综合征(MS)的影响。方法随机选取144例1型糖尿病病人,依据病程长短分为A组(病程<5年)、B组(病程5~15年)、C组(病程>15年),分析比较3组病人体质量指数(BMI)、血总胆固醇(TC)、三酰甘油(TG)、血尿酸(UA)水平及并发MS情况。结果C组病人BMI明显高于A组,差异有显著性(F=3.449,q=3.656,P<0.05);C组病人血TC、TG、UA水平及MS发生率明显高于B组,B组明显高于A组,差异有显著性(F=5.60~90.25,q=3.122~18.988,P<0.01;χ2=8.52,P<0.05)。结论随着病程延长,1型糖尿病病人BMI、血TC、TG、UA水平逐渐升高,MS发生率增加。 Objective To investigate the relationship between the course of type 1 diabetes and lipid, uric acid levels as well as metabolic syndromes (MS). Methods This study consisted of 144 patients, who were divided into groups A, B and C according to the courses of disease. Group A (〈 5 years); groupB (5-15 years); and groupC (〉15 years). The body mass index (BMI), serum levels of TC, TG, UA and the prevalence of MS were compared among the three groups. Results The BMI of group C was higher than group A (F=3. 449,q=3. 656,P〈0.05). The serum level of TC, TG, UA and MS of group C were higher than those of groups C, and those of group B were higher than group A (F≈5.60-90.25,q=3,122-18. 988,P〈0.01; χ^2 =8.52,P〈0.05). Conclusion BMI, the serum levels of TC, TG, UA and the prevalence of MS were increased with the increase of course-duration of type 1 diabetes.
出处 《青岛大学医学院学报》 CAS 2007年第6期487-488,491,共3页 Acta Academiae Medicinae Qingdao Universitatis
关键词 糖尿病 1型 胆固醇 甘油三酯类 尿酸 代谢综合征 diabetes mellitus, type 1 cholesterol triglycerides uric acid metabolic syndrome
  • 相关文献

参考文献12

  • 1中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3058
  • 2BONORA E, TARGHER G, ZENERE M B, et al. Relationship of uric acid concentration to cardiovascular risk factors in young men, role of obesity and central fat distribution, the verona young men atherosclerosis risk factors study[J]. Int J Obes Relat Metab Disord, 1996,20(11):975-980.
  • 3LAI S W, LI T, NG K. Hyperuricaemia and its related factors in Taiwan middle aged adults[J]. Int J Pract, 2002,8(1):56-60.
  • 4CHU N F, WANG D J, LIOU S H, et al. Relationship between hyperuricemia and other cardiovascular disease risk factors among adult makes in Taiwan[J]. Eur J, 2000,16(1):13-17.
  • 5WORTMANN R L. Gout and hyperuricemia[J]. Curr Opin Rheumatol, 2002,14(3):281-286.
  • 6GHEIIM, MIHAILESEU M, LEVINSON D. Pathogenesis of hyperuricemia:recent advances[J]. Curr Rheumatol Rep, 2002,4(3):270-274.
  • 7CARDONA F, TINAHONES F J, COLLANTES E, et al. The elevated prevalence of apolipoprotein E in patients with gout is associated with reduced renal excretion of urates[J]. Rheum, 2003,42:468-472.
  • 8NIETRO F J, IRIBARREN C, GROSS M D, et al. Uric acid and serum antioxidant capacity:a reaction to atherosclerosis[J]. J Atherosclerosis, 2000,148:131-139.
  • 9贾少丹,王颜刚,苗志敏,闫胜利.高尿酸血症对血管内皮细胞功能障碍的影响[J].青岛大学医学院学报,2004,40(3):216-218. 被引量:20
  • 10TOMITA M, MIZUNO S, YAMANAKA H, et al. Does hyperuricemia affect mortality?A prospective cohort study of Japanese male workers[J]. J Epidemiol, 2000,10:403-409.

二级参考文献6

共引文献3074

同被引文献16

  • 1Mukai K, Obata K, Tsujimura Y, et al. New Insights into the Roles for Basophils in Acute and Chronic Allergy. Allergol Int,2009,58:11-19.
  • 2Wierzbicki M, Brzezinska-Biaszczyk E. The role of mast cells in the de- velopment of inflammatory bowel diseases. Postepy Hig Med Dosw (Online) ,2008,62:642-650.
  • 3Stafforini DM. Biology of platelet-activating factor acetylhydrolase (PAF-AH, lipoprotein associated phospholipase A2). Cardiovase Drugs Ther, 2009, 23: 73-83.
  • 4Salluh JI, Pino AV, Silva AR, et al. Lung production of platelet-acfivaring factor acetylhydrolase in oleic acid-induced acute lung injury. Prostaglandins Leukot Essent Fatty Acids,2007,77 : 1-8.
  • 5Briede J, Heidemanis K, Dabina I, et al. Effect of eerebrocrast on the function of human platelets and release of the arachidonie acid from plasma membrane. Cell Biochem Funct ,2002,20 : 177-181.
  • 6Dart G,Chiarelli F,Santilli F,et al. Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus :role of interleukin-6 and disease duration. Circulation, 21XB ,107:3199-3203.
  • 7Vukkadapu SS, Belli JM. Dynamic interaction between T cell-mediated- cell damage and -cell repair in the run up to autoimmune diabetes of the NOD mouse. Physiol Geuomics ,2005,21 : 201-211.
  • 8Castro SH, Faria HC, Gomes MB. Platelet-activating factor acetylhydrolase (PAF-AH)activity in patients with type 1 diabetes mellitus. Arq Bras Cardiol,2007,88 : 179-184.
  • 9Cavallo-Perin P, Lupia E, Gruden G, et al. Increased blood levels of platelet-activanting factor in insulin-dependent diabetic patients with microalbuminuria. Nephrol Dial Transplant,2000, 15 : 994-999.
  • 10Miwa M, Miyake T, Yamanaka T, et al. Characterization of serum platelet-activating factor (PAF) acetylhydrolase. Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children. J Clin Invest,1988,82(6) :1983-1991.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部